Dedicated to increasing the number of donor organs available for transplant. Sofina has an observer seat in the decision-making bodies of the company.
Investment highlights
2008
Year of establishment
United Kingdom
Country
2025
Year of entry
Healthcare and life sciences
Sector
OrganOx is a high-growth, commercial-stage medical device company active in organ preservation and transplantation devices with a first product for liver preservation. NMP technology (Normothermic Machine Perfusion) is rapidly establishing itself as the new standard of care for organ transplantation. NMP improves organ function and allows for a viability assessment before transplant, which enables the usage of a much broader range of donor organs than would otherwise be discarded due to rejection risk.